D, K., C, P., F, G., M, A., V, A., S, B., . . . M, S. (2025). Evaluating genome sequencing strategies: Trio, singleton, and standard testing in rare disease diagnosis. Genome medicine, 17(1), 100. https://doi.org/10.1186/s13073-025-01516-7
Chicago Style (17th ed.) CitationD, Kaschta, et al. "Evaluating Genome Sequencing Strategies: Trio, Singleton, and Standard Testing in Rare Disease Diagnosis." Genome Medicine 17, no. 1 (2025): 100. https://doi.org/10.1186/s13073-025-01516-7.
MLA (9th ed.) CitationD, Kaschta, et al. "Evaluating Genome Sequencing Strategies: Trio, Singleton, and Standard Testing in Rare Disease Diagnosis." Genome Medicine, vol. 17, no. 1, 2025, p. 100, https://doi.org/10.1186/s13073-025-01516-7.
Warning: These citations may not always be 100% accurate.